Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The use of the Percutaneous Isolated Limb Procedure (PILP) which enables the use of existing
antibiotic therapies in a more targeted and concentrated fashion in patients with diabetes
who have a significant lower limb infection and it is deemed that IV antibiotics are needed
in order to salvage the limb or life.